Tonix Pharmaceuticals Holding Corp (TNXP)
0.1835
+0.01
(+7.25%)
USD |
NASDAQ |
May 03, 16:00
0.1723
-0.01
(-6.10%)
After-Hours: 20:00
Tonix Pharmaceuticals Shareholders Equity (Quarterly): 105.52M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 105.52M |
September 30, 2023 | 120.83M |
June 30, 2023 | 140.46M |
March 31, 2023 | 165.43M |
December 31, 2022 | 207.18M |
September 30, 2022 | 228.92M |
June 30, 2022 | 259.78M |
March 31, 2022 | 207.96M |
December 31, 2021 | 218.72M |
September 30, 2021 | 202.22M |
June 30, 2021 | 180.49M |
March 31, 2021 | 176.92M |
December 31, 2020 | 87.65M |
September 30, 2020 | 62.57M |
June 30, 2020 | 53.57M |
March 31, 2020 | 31.25M |
December 31, 2019 | 9.417M |
September 30, 2019 | 9.855M |
June 30, 2019 | 12.82M |
March 31, 2019 | 17.81M |
December 31, 2018 | 23.66M |
September 30, 2018 | 13.71M |
June 30, 2018 | 15.84M |
March 31, 2018 | 18.61M |
December 31, 2017 | 24.62M |
Date | Value |
---|---|
September 30, 2017 | 28.68M |
June 30, 2017 | 33.97M |
March 31, 2017 | 21.98M |
December 31, 2016 | 25.36M |
September 30, 2016 | 27.10M |
June 30, 2016 | 30.03M |
March 31, 2016 | 27.34M |
December 31, 2015 | 40.26M |
September 30, 2015 | 52.65M |
June 30, 2015 | 46.24M |
March 31, 2015 | 56.89M |
December 31, 2014 | 36.09M |
September 30, 2014 | 43.78M |
June 30, 2014 | 42.66M |
March 31, 2014 | 47.92M |
December 31, 2013 | 6.512M |
September 30, 2013 | 5.436M |
June 30, 2013 | -1.964M |
March 31, 2013 | -0.6397M |
December 31, 2012 | 0.959M |
September 30, 2012 | -0.6743M |
June 30, 2012 | 0.7149M |
March 31, 2012 | -0.3789M |
December 31, 2011 | -2.454M |
September 30, 2011 | -0.015M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
9.417M
Minimum
Dec 2019
259.78M
Maximum
Jun 2022
130.61M
Average
140.46M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
PetVivo Holdings Inc | 0.8951M |
Acurx Pharmaceuticals Inc | 57.89M |
Kezar Life Sciences Inc | 187.57M |
Allakos Inc | 168.82M |
RAPT Therapeutics Inc | 147.04M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 154.46M |
Total Liabilities (Quarterly) | 48.93M |
Debt to Equity Ratio | 0.0844 |
Current Ratio | 2.530 |